August 25, 2015 | Navidea Biopharmaceuticals announced that it would register its shares in a dual listing on the Tel Aviv Stock Exchange (TASE). The biopharmaceutical company that produces precision diagnostics, therapeutics and radiopharmaceutical agents is already listed on the New York Stock Exchange. Dual listing on the TASE is allowed in the United States and Israel without any additional regulatory requirements. Navidea Biopharmaceuticals is headquartered in Ohio.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments